Publications
- Plasma concentrations of angiogenic activators VEGF and bFGF in patients with multiple myeloma, follicular lymphoma, and diffuse large B-cell lymphoma, and chronic myeloid leukemia +1Publication without faculty affiliation
- Association of lgVH mutation status and plasma levels of angiogenic activators in chronic lymphocytic leukemia: significantly higher bFGF but not VEGF in IgVH mutated patients +1Publication without faculty affiliation
- Plasma concentrations of angiogenic activators VEGF and bFGF in patients with multiple myeloma, follicular lymphoma, diffuse large B-cell lymphoma, and chronic myeloid leukemia +1Publication without faculty affiliation
- Association of IgVH mutation status and plasma levels of angiogenic activators in chronic lymphocytic leukemia : Significantly higher bFGF but not VEGF in IgVH mutated patientsPublication without faculty affiliation
- Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders2019 | Faculty of Medicine in Hradec Králové
- Treatment of elderly and comorbid patients with chronic lymphocytic leukemia2017 | Faculty of Medicine in Hradec Králové
- Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies2017 | Faculty of Medicine in Hradec Králové
- Primary testicular lymphoma2017 | Faculty of Medicine in Hradec Králové
- Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
Loading network view...